RVNC insider trading

CIK 1479290

Revance Therapeutics, Inc.: insider trade history from SEC Form 4 filings.

Form 4 trades
467
Last 90 days
0
Buys / sells
2% / 24%
Insiders
27

RVNC insider activity at a glance

FilingIQ tracks 467 insider transactions for RVNC in filings since Jan 13, 2015. The most recent transaction is dated Feb 6, 2025. They were reported by 27 insiders.

Across the full history, 8 open-market purchases and 110 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.

Latest RVNC Form 4 filings

Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.

Tickers with similar insider activity

Ranked next to RVNC by Form 4 lines in the last 90 days, the number on each card.

Frequently asked

How many insider trades does FilingIQ track for RVNC?
FilingIQ tracks 467 Form 4 insider transactions for RVNC (Revance Therapeutics, Inc.), covering filings from Jan 13, 2015 onwards. 0 of those are dated within the last 90 days.
Are RVNC insiders net buyers or net sellers?
Across the full Form 4 history for RVNC, 8 transactions (2%) were open-market purchases and 110 (24%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does RVNC insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.

Methodology & sources

Every RVNC insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Institutional holder counts come from the quarter's SEC Form 13F reports. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.